Clinical Trial Update: Pharmacodynamics of Omiganan (CLS001) in Patients With Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 pharmacodynamics update of Omiganan (CLS001) in patients with atopic dermatitis, providing pharmacodynamic data from the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Omiganan (omiganan)

Snippet

Sponsor: Maruho Co., Ltd. | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED